Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$104,062
-$299,961 QoQ
Shares Held
664
-74.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,371
of 1,603 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Preferred, LLC holds $5,804,895 across 5 Drug Manufacturers - General names. NVS ranks #5 (1.8% of the industry book) .
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,062 | 664 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $404,023 | 2,645 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $78,585 | 570 | Shares | Other | 2026-02-02 | |
| 2024-12-31 | $126,989 | 1,305 | Shares | Other | 2025-01-28 | |
| 2023-12-31 | $270,498 | 2,679 | Shares | Other | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||